Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease
Mattia Siciliano1, Rosa De Micco2, Valeria Sant'Elia2
1Department of Advanced Medical and Surgical Sciences - MRI Research Center Vanvitelli-FISM, University of Campania "Luigi Vanvitelli", Piazza Miraglia 2, 80138, Naples, Italy; Department of Psychology, University of Campania "Luigi Vanvitelli", Viale Ellittico 31, 81100, Caserta, Italy.
Introduction:
Mild cognitive impairment is a common feature of Parkinson's disease (PD-MCI), even at the earliest disease stages. Growing evidence supports the instability of PD-MCI over time, without a consistent linear evolution to dementia, and in some patients, the potential of reversion to normal cognition. However, which features are associated with reversion from PD-MCI to normal cognition in early PD-MCI are not fully known.
Methods:
In our longitudinal study of early drug naïve PD patients, 65 of 134 (48 %) patients had PD-MCI at baseline. Study participants underwent comprehensive assessments at baseline and 1-year follow-up. Sixteen (24.6 %) patients with PD-MCI reverted to normal cognition (Reverters), and 49 (75.4 %) had persistent PD-MCI (Non-Reverters) after 1-year follow-up. We performed single- and multiple-variable logistic regression analyses to identify baseline variables predicting reversion of PD-MCI to normal cognition after 1-year. We also compared brain morphometric measures (cortical thickness and volumes) at baseline between the PD-MCI Reverters and Non-Reverters.
Results:
Higher educational level and better performance on measures of attention and memory at baseline predicted the reversion to normal cognition at 1-year follow-up. Reverters had greater cortical thickness in the left inferior temporal gyrus than Non-Reverters.
Conclusions:
Our results show PD-MCI with a higher chance of reverting to normal cognition over time have a higher educational level, better frontotemporal-related cognitive function, and increased thickness of the inferior temporal lobe gyrus. These findings may potentially help researchers to select the candidates for clinical trials focusing on the treatment of cognitive impairment in the early stages of PD.
Insights
Parkinson's disease with mild cognitive impairment may improve over time. Higher education, better attention, and memory at baseline are linked to cognitive reversion in PD-MCI patients.
Area of Science:
- Neuroscience
- Neurology
- Cognitive Science
Background:
- Mild cognitive impairment (MCI) is prevalent in early Parkinson's disease (PD-MCI).
- PD-MCI exhibits variable progression, with potential for reversion to normal cognition.
- Predictors of cognitive reversion in early PD-MCI remain unclear.
Purpose of the Study:
- To identify baseline factors associated with reversion from PD-MCI to normal cognition.
- To explore brain morphometric differences between PD-MCI patients who revert and those who do not.
Main Methods:
- Longitudinal study of 134 early, drug-naïve Parkinson's disease patients.
- Comprehensive cognitive and brain morphometric assessments at baseline and 1-year follow-up.
- Logistic regression and comparison of cortical thickness/volumes between Reverters and Non-Reverters.
Main Results:
- 48% of patients had PD-MCI at baseline; 24.6% reverted to normal cognition within 1 year.
- Higher education and better attention/memory predicted reversion.
- Reverters showed greater left inferior temporal gyrus cortical thickness.
Conclusions:
- Higher educational attainment and preserved frontotemporal cognitive function are associated with PD-MCI reversion.
- Increased inferior temporal lobe thickness may indicate a higher likelihood of cognitive recovery.
- Findings aid in identifying candidates for early Parkinson's disease cognitive impairment clinical trials.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Development During Adulthood


